Report Feature
The future of the genotyping market looks promising with opportunities in diagnostics, drug discovery personalized medicine, academic research, and agriculture applications. The global genotyping market is expected to grow with a CAGR of 20%-25% from 2020 to 2025. The major drivers for this market are increasing research and development activities in the healthcare sector, rising prevalence of genetic diseases, and technological advancement in gene studies.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genotyping market report, please download the report brochure.
In this market, reagents & kits is the largest product of genotyping, whereas personalized medicine is the largest application. Growth in various segments of the genotyping market are given below:
The study includes trends and forecast for the global genotyping market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Reagents and Kits
- Instruments
- Services
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- PCR (Polymerase Chain Reaction)
- Capillary Electrophoresis
- Mass Spectrometry
- Sequencing
- Microarray
- Others
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Diagnostics
- Drug Discovery and Development
- Personalized Medicine
- Academic Research
- Agricultural Biotechnology and Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceutical & Biopharmaceutical Companies
- Diagnostic & Research Laboratories
- Academic Institutes
- Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the genotyping model companies profiled in this report includes QIAGEN, Affymetrix, Illumina, Thermo Fisher Scientific, General Electric, Agilent Technologies, and Roche.
Lucintel forecasts that reagents and kits will remain the largest product segment over the forecast period due to a wide usage rate, surging demand for genotyping tests, cost-effectiveness, and easy availability of reagents.
Within this market, personalized medicine will remain the largest application segment over the forecast period due to rising government support for personalized medicine, changing reimbursement and regulatory landscape, and the growing adoption of sequencing for genetic mapping.
North America will remain the largest region over the forecast period due to the well-established healthcare infrastructure and rapid advancements in technology in the region.
|
Features of the Global Genotyping Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global genotyping market by product (reagents and kits, instruments, and services), technology (PCR (polymerase chain reaction), capillary electrophoresis, mass spectrometry, sequencing, microarray, and others), application (diagnostics, drug discovery and development, personalized medicine, academic research, and agricultural biotechnology & others), end user (pharmaceutical & biopharmaceutical companies, diagnostic & research laboratories, academic institutes, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genotyping market? Q.5 What are the business risks and threats to the global genotyping market? Q.6 What are the emerging trends in this genotyping market and the reasons behind them? Q.7 What are some changing demands of customers in this genotyping market? Q.8 What are the new developments in this genotyping market? Which companies are leading these developments? Q.9 Who are the major players in this genotyping market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this genotyping market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global genotyping market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Reagents and Kits, Instruments, and Services), Technology (PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Genotyping Market
4.1 Global Genotyping Market by Region
4.2.1 Market by Product: Reagents and Kits, Instruments, and Services
4.2.2 Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.2.3 Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.2.4 Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.2.5 The United States Genotyping Market
4.2.6 The Canadian Genotyping Market
4.2.7 The Mexican Genotyping Market
4.3.1 Market by Product: Reagents and Kits, Instruments, and Services
4.3.2 Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.3.3 Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.3.4 Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.3.5 The United Kingdom Genotyping Market
4.3.6 The Spanish Genotyping Market
4.3.7 The German Genotyping Market
4.3.8 The French Genotyping Market
4.4.1 Market by Product: Reagents and Kits, Instruments, and Services
4.4.2 Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.4.3 Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.4.4 Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.4.5 The Chinese Genotyping Market
4.4.6 The Indian Genotyping Market
4.4.7 The Japanese Genotyping Market
4.5.1 Market by Product: Reagents and Kits, Instruments, and Services
4.5.2 Market by Technology: PCR (Polymerase Chain Reaction), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray, and Others
4.5.3 Market by Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, and Agricultural Biotechnology & Others
4.5.4 Market by End User: Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Other End Users
4.5.5 Brazilian Genotyping Market
7.1.1 Growth Opportunities for the Global Genotyping Market by Product
7.1.2 Growth Opportunities for the Global Genotyping Market by Technology
7.1.3 Growth Opportunities for the Global Genotyping Market by Application
7.1.4 Growth Opportunities for the Global Genotyping Market by End User
7.1.5 Growth Opportunities for the Global Genotyping Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
